Determination of lonazolac and its hydroxy and O-sulfated metabolites by on-line sample preparation liquid chromatography with fluorescence detection

被引:46
作者
Friedrich, G
Rose, T
Rissler, K
机构
[1] Inst Contract Res, Pharmbiodyn, D-79207 Denzlingen, Germany
[2] Ciba Specialty Chem Inc, CH-4002 Basel, Switzerland
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 766卷 / 02期
关键词
lonazolac; hydroxylonazolac; methyllonazolac;
D O I
10.1016/S0378-4347(01)00514-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reliable method, which can be used for the determination of lonazolac and its hydroxylated and O-sulfated metabolites in cell culture media with methyllonazolac as the internal standard is described. The procedure employs on-line sample enrichment using a BioTrap 500 MS(TM) (20 x 4 mm I.D.) extraction pre-column and subsequent gradient separation on an Xterra MS C-18-H(TM) (100 x 3 run I.D., 3.5 mum particles) analytical column in the back-flush mode. Signal monitoring was done by measurement of fluorescence responses at 273 nm for excitation and 385 nm for emission. Structural identity of analyte peaks was confirmed by liquid chromatography coupled to mass spectroscopy (LC-MS-MS) using an electrospray ionization (ESI) source in the selected reaction monitoring (SRM) mode. Mean recoveries of lonazolac, hydroxylonazolac and lonazolac sulfate, respectively, from the biological matrix were 104.2 +/- 3.5, 96.7 +/- 2.2, and 100.9 +/- 3.5%. The limit of detection (LOD) fur the three compounds was about 5 ng/ml using a total sample volume of only 50 mul. Linearity of signal responses versus concentration for all three analytes was accomplished in the range 10-600 ng/ml. The mean values of the coefficients of variation (CM) for quality control samples measured in duplicate at three different days at the 10, 40, 100, and 400 ng/ml level were 4.46 +/- 1.15, 3.94 +/- 2.13 and 4.79 +/- 2.07% for lonazolac, hydroxylonazolac and lonazolac sulfate. The target analytes were sufficiently stable at both storage and sample preparation conditions because no substantial deviations between analyte concentrations measured before and after subsequently performed freeze and thaw cycles were observed. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:295 / 305
页数:11
相关论文
共 12 条
[1]   COLUMN SWITCHING IN HPLC - DETERMINATION OF DRUG SUBSTANCES IN BIOLOGICAL-MATERIAL [J].
ARNOLD, PJ ;
GUSERLE, R ;
WORZ, M ;
LUCKOW, V .
CHROMATOGRAPHIA, 1986, 22 (7-12) :431-431
[2]  
Baeyens W. R. G., 1995, Biomedical Chromatography, V9, P263, DOI 10.1002/bmc.1130090608
[3]  
Baeyens W. R. G., 1995, Biomedical Chromatography, V9, P261, DOI 10.1002/bmc.1130090607
[4]   SEPARATION AND IDENTIFICATION OF NONSTEROIDAL ANTIRHEUMATIC DRUGS CONTAINING A FREE CARBOXYL FUNCTION USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BATTISTA, HJ ;
WEHINGER, G ;
HENN, R .
JOURNAL OF CHROMATOGRAPHY, 1985, 345 (01) :77-89
[5]  
Deneke J, 1998, INT J CLIN PHARM TH, V36, P418
[6]   DIRECT INJECTION OF BIOLOGICAL-FLUIDS - APPLICATION OF HPLC-ANALYSIS WITH PRECOLUMN ENRICHMENT TO THE PHARMACOKINETIC STUDIES OF LONAZOLAC [J].
HUBER, R ;
ZECH, K ;
WORZ, M ;
KRONBACH, T ;
VOELTER, W .
CHROMATOGRAPHIA, 1982, 16 :233-236
[7]  
RIEDEL R, 1981, ARZNEIMITTEL-FORSCH, V31-1, P655
[8]   FULLY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - A NEW CHROMATOGRAPH FOR PHARMACOKINETIC DRUG-MONITORING BY DIRECT INJECTION OF BODY-FLUIDS [J].
ROTH, W ;
BESCHKE, K ;
JAUCH, R ;
ZIMMER, A ;
KOSS, FW .
JOURNAL OF CHROMATOGRAPHY, 1981, 222 (01) :13-22
[9]  
SCHULZ M, 1989, PZ WISS, V2, P41
[10]  
SIMON WA, 1987, P EUR C BIOPH PHARM, V2, P606